CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | ARBEL IRIT Director | Grant or award | +120,000 | 161,054 | ||
| 2025-01-01 | ARBEL IRIT Director | Grant or award | +30,666 | 41,054 | ||
| 2021-12-15 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2021-12-10 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2019-12-12 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2019-08-28 | ARBEL IRIT Director | Exercise or conversion | +6,666 | $2.25 | $15K | 162,499 |
| 2019-08-28 | ARBEL IRIT Director | Exercise or conversion | +6,666 | $2.25 | $15K | 169,165 |
| 2019-08-28 | ARBEL IRIT Director | Sale | −13,332 | $3.67 | $49K | 155,833 |
| 2019-08-28 | ARBEL IRIT Director | Exercise or conversion · Stock Option (right to buy) | −6,666 | 0 | ||
| 2019-08-28 | ARBEL IRIT Director | Exercise or conversion · Stock Option (right to buy) | −6,666 | 0 | ||
| 2018-11-30 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2017-11-10 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2017-08-31 | ARBEL IRIT Director | Purchase | +2,500 | $4.26 | $11K | 155,833 |
| 2017-07-13 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-02-26 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2016-06-22 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2015-08-27 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +25,333 | 25,333 | ||
| 2015-06-01 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +6,667 | 6,667 | ||
| 2014-08-15 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +380,000 | 380,000 | ||
| 2013-04-19 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 |
Page 1 of 2 · 21 trades